ENTERA BIO LTD (ENTX)
IL0011429839 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ENTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 410% above the current price.
ENTX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ENTX.
In the previous month the buy percentage consensus was at a similar level.
ENTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-06 | HC Wainwright & Co. | Initiate | Buy |
| 2022-07-19 | B. Riley Securities | Maintains | Buy |
| 2021-06-16 | B. Riley Securities | Initiate | Buy |
| 2021-03-22 | Aegis Capital | Initiate | Buy |